s-methylisothiopseudouronium has been researched along with Ventricular Dysfunction, Left in 2 studies
S-methylisothiopseudouronium: inhibits nitric oxide synthase; structure in first source
Ventricular Dysfunction, Left: A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, B | 1 |
| Larson, DF | 1 |
| Watson, RR | 1 |
| Pinto, VD | 1 |
| Cutini, GJ | 1 |
| Sartório, CL | 1 |
| Paigel, AS | 1 |
| Vassallo, DV | 1 |
| Stefanon, I | 1 |
2 other studies available for s-methylisothiopseudouronium and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Modulation of iNOS activity in age-related cardiac dysfunction.
Topics: Aging; Animals; Arginine; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fluoresce | 2004 |
Enhanced beta-adrenergic response in rat papillary muscle by inhibition of inducible nitric oxide synthase after myocardial infarction.
Topics: Adrenergic beta-Agonists; Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; Isoprotereno | 2007 |